|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/64 |
| (11) | Patento numeris | 2635677 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11781973.0 |
| Europos patento paraiškos padavimo data | 2011-11-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-09-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-01-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/059233 |
| Data | 2011-11-03 |
| (87) | Numeris | WO 2012/061654 |
| Data | 2012-05-10 |
| (30) | Numeris | Data | Šalis |
| 456298 P | 2010-11-03 | US |
| (72) |
MADISON, Edwin, L., US
THANOS, Christopher, US
BLOUSE, Grant, Ellsworth, DK
|
| (73) |
Catalyst Biosciences, Inc.,
611 Gateway Blvd., Suite 710, South San Francisco, CA 94080,
US
|
| (54) | MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF |
| MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF |